KPMG US announced that DEA submitted a final rule to the White House to establish a permanent special registration pathway for prescribing controlled substances via telehealth, replacing temporary pandemic-era flexibilities extended through December 31, 2026.
Public source
Publisher name
Public post
DEA submitted a final rule to the White House to establish a permanent special registration pathway for prescribing controlled substances via telehealth, replacing tempo…
Company
KPMG US
KPMG LLP, the U.S. audit, tax & advisory firm, operates from 80+ offices and over 36,000 partners and professionals.
- Industry
- Financial Services
- Location
- New York, US
- Company size
- 10,001+ employees
About KPMG US
KPMG is one of the world’s leading professional services firms and the fastest growing Big Four accounting firm in the United States. With 90+ offices and more than 36,000 employees and partners throughout the US, we’re leading the industry in new and exciting ways. Our size and strength make us much more agile and responsive to changing trends.
See moreLatest activity
Latest activity from KPMG US
266 signals
Presence & Recognition
KPMG US is hosting a virtual KPMG 101 & Accounting Career Fair featuring a 30-minute live presentation, one-on-one conversations with professionals, and an opportunity to expand the network.
Partnerships
KPMG US worked alongside KPMG LLP on the successful go-live of Workday and UKG at Children’s National Hospital
Presence & Recognition
KPMG US is hosting a strategic planning, risk management, and investment decision forum featuring KPMG chief economists and global geopolitics leaders on September 24.
Discover more
Similar signals
Similar public activity from other companies.
Legal & Regulatory
KPMG
KPMG Healthcare published a report titled Around the World of U.S. Healthcare, which includes a final rule submitted by DEA to the White House to establish a permanent special registration pathway for prescribing controlled substances via telehealth, replacing temporary pandemic-era flexibilities extended through December 31, 2026.
Legal & Regulatory
Polsinelli
Polsinelli notes that a significant Medicare enrollment obstacle has been permanently removed for many telehealth arrangements, providing certainty for practitioners and group practices.
Legal & Regulatory
QuickMD
QuickMD notes that the FDA will hold a public meeting later this week on opioid medications and their use in pain and addiction treatment.
Legal & Regulatory
SJKP, LLP
SJKP, LLP published an update covering the SEC and FDA agreement providing a formal channel for the FDA to share non-public information with the SEC.
Legal & Regulatory
Elevare Law